SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?


To: StockDung who wrote (1970)5/25/2000 10:54:00 PM
From: afrayem onigwecher  Read Replies (2) | Respond to of 3392
 
The 6-to-9-month target price is $40.00 per share.

Cyber-Care Rated New 'Buy' at First Liberty(Correct)
3/2/00 11:55:00 AM
Source: Bloomberg News


Quote Snapshot
CYBR 3.94 -1.13

ú Messages

Enter symbol:

ú Symbol Lookup

sponsored by

Quotes delayed 20+ minutes
Trade Now
with our broker sponsors


(Corrects the name of the firm to First Liberty Investment Group.)

Princeton, New Jersey, March 2 (Bloomberg Data) -- Cyber-Care Inc. (CYBR US) was rated new ''buy'' in new coverage by analyst Sheldon S Traube at First Liberty Investment Group. The 6-to-9-month target price is $40.00 per share.
More Broker Reports

Email this story to a friend Click for printer-friendly format